Phase I pharmacologic study of oral topotecan and intravenous cisplatin: sequence-dependent hematologic side effects (Q33332454)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
Phase I pharmacologic study of oral topotecan and intravenous cisplatin: sequence-dependent hematologic side effects
scientific article

    Statements

    Phase I pharmacologic study of oral topotecan and intravenous cisplatin: sequence-dependent hematologic side effects (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit